Song Z, Lian S, Mak S, Chow MZ, et al. Deep RNA sequencing revealed fusion junctional heterogeneity may predict crizotinib treatment efficacy in ALK-rearranged non-small cell lung cancer. J Thorac Oncol 2021 Oct 6. pii: S1556-0864(21)03219.
PMID: 34626839